Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10064398 Animal models and therapeutic molecules

Patent 10064398 was granted and assigned to Kymab on September, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Kymab
Kymab
0
Date Filed
October 16, 2014
0
Date of Patent
September 4, 2018
0
Patent Applicant
Kymab
Kymab
0
Patent Application Number
14516461
0
Patent Citations Received
‌
US Patent 12004495 Genetically modified non-human animals with humanized immunoglobulin locus
0
‌
US Patent 10667501 Transgenic non-human vertebrate for the in vivo production of dual specificity immunoglobulins or hypermutated heavy chain only immunoglobulins
‌
US Patent 11564380 Animal models and therapeutic molecules
‌
US Patent 11606941 Animal models and therapeutic molecules
0
‌
US Patent 11707056 Animals, repertoires and methods
0
‌
US Patent 11297810 Animal models and therapeutic molecules
‌
US Patent 11297811 Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies
‌
US Patent 11399522 Animal models and therapeutic molecules
‌
US Patent 11997994 Genetically modified non-human animals with common light chain immunoglobulin locus
0
Patent Inventor Names
Qi Liang
0
Wei Wang
0
Allan Bradley
0
E-Chiang Lee
0
Glenn Friedrich
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10064398
0
Patent Primary Examiner
‌
Anoop Kumar Singh
0

Find more entities like US Patent 10064398 Animal models and therapeutic molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.